Table 1.
Clinicopathologic variables | frequency | % | |
---|---|---|---|
Patient gender | male | 18 | 40.0 |
female | 27 | 60.0 | |
Tumor type | Low-grade MEC | 7 | 15.6 |
High-grade MEC | 13 | 28.9 | |
Adenoid cystic carcinoma | 12 | 26.7 | |
Carcinoma ex pleomorphic adenoma | 8 | 17.8 | |
Acinic cell carcinoma | 5 | 11.1 | |
Histologic grade | Low-grade carcinomas | 12 | 26.7 |
High-grade carcinomas | 33 | 73.3 | |
Tumor site | parotid salivary gland | 23 | 51.1 |
Submandibular salivary gland | 12 | 26.7 | |
Soft and hard palate minor salivary glands | 5 | 11.1 | |
Sublingual major salivary gland | 4 | 8.9 | |
Retromolar mucosa | 1 | 2.2 | |
Tumor size | T1 | 7 | 15.6 |
T2 | 12 | 26.7 | |
T3 | 17 | 37.8 | |
T4 | 9 | 20.0 | |
Status of nodal involvement | positive nodal involvement | 26 | 57.8 |
negative nodal involvement | 19 | 42.2 | |
Distant metastasis | present | 17 | 37.8 |
absent | 28 | 62.2 | |
TNM stage | stage I | 7 | 15.6 |
stage II | 6 | 13.3 | |
stage III | 13 | 28.9 | |
stage IV | 19 | 42.2 | |
Incidence of recurrence | Present | 17 | 37.8 |
Absent | 28 | 62.2 | |
Incidence of death | Died | 5 | 11.1 |
Alive | 40 | 88.9 | |
CTSK expression | Negative expression | 8 | 17.8 |
Weak expression | 8 | 17.8 | |
Moderate expression | 6 | 13.3 | |
Strong expression | 23 | 51.1 | |
Total | 45 | 100 |
Frequency table